Truist Financial analyst Srikripa Devarakonda reiterated a Buy rating on Tourmaline Bio (TRML – Research Report) today. The company’s shares closed yesterday at $25.00. Pick the best stocks ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈